Japan Diabetes Outcome Intervention Trial-1(J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups: rationale, design, and recruitment
Naoki Sakane(Kyoto Medical Center), Hideshi Kuzuya(Unknown), Mitsuhiko Noda(International University of Health and Welfare), Sadao Suzuki(Nagoya City University), Kazuhiko Kotani(Jichi Medical University), Kazuo Izumi(National Center for Global Health and Medicine), Yoshiko Sano(Kyoto Medical Center), Naoki Ishizuka(Iwate Medical University), Satoshi Morita(Yokohama City University), K. Okazaki(Nagoya University), Juichi Sato(Nagoya University Hospital), Masayuki Kato(MSD K.K. (Japan)), Kaoru Takahashi(The Cancer Institute Hospital), Kokoro Tsuzaki(Kyoto Medical Center)
Cited by 8
Related Papers
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
|Nature Medicine|2002|4.2k
What has made the population of Japan healthy?
|The Lancet|2011|677
Descriptive Epidemiology of Kawasaki Disease in Japan, 2011–2012: From the Results of the 22nd Nationwide Survey
|Journal of Epidemiology|2015|339
Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart
|Biochemical Journal|1998|310